Originally developed as an anti-obesity drug candidate in the late 1990s, it has since found research applications in both metabolic studies and cartilage repair investigations
Alexandra Sowa, M.D., a New York City-based physician double-board certified in internal medicine and obesity medicine, and the author of The Ozempic Revolution
Similarly, both study designs were double-blind, randomized, and placebo-controlled, but while the first study had two arms parallel-design (control and test), the second was a crossover, with two cycles of 12 weeks for each treatment, Placebo and Eriomin
Sustained lifestyle changes are vital to help protect muscle and support weight stability during and after treatment
Patients should be aware that whilst some fatigue during weight loss is normal, persistent or severe symptoms warrant medical review